about
A retro-inverso cell-penetrating peptide for siRNA delivery.BET bromodomain inhibitors synergize with ATR inhibitors in melanoma in melanomaAcquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling.Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.Efficient in vivo transfection and safety profile of a CpG-free and codon optimized luciferase plasmid using a cationic lipophosphoramidate in a multiple intravenous administration procedure.Lipothiophosphoramidates for gene delivery: critical role of the cationic polar headgroup.Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model.BET bromodomain inhibitors synergize with ATR inhibitors in melanoma.A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanomaNovel Mouse Tauopathy Model for Repetitive Mild Traumatic Brain Injury: Evaluation of Long-Term Effects on Cognition and Biomarker Levels After Therapeutic Inhibition of Tau PhosphorylationHER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice
P50
Q30847307-E1AF4094-7EB8-4657-AFD1-15BA24F01945Q38630705-EDBCB924-9223-40BD-8BF2-92570F93CA79Q38665896-D7BC5D1D-C0D8-420E-A61D-A59DDEDE61C8Q38768534-E8F14DB7-58BC-44C0-B8B7-2DF117181AE0Q38878953-CA851A7A-6829-49F0-BA91-25EA0A948D16Q39403585-37152D7A-6767-4046-922D-8A5FE32453A1Q41915301-1AE0722F-0D42-4C8D-A9A9-65A74A93BB8FQ49841840-303A2440-CD28-4CC3-8439-446BD7EC5EC0Q57174849-5AA5DCA5-61E4-4B3C-B084-78D9A8DA17BAQ64107328-8569615C-12B4-4FEB-9175-68FAC9CE8247Q90949076-08A1DD39-87AB-43AD-BEF9-47053747B9D5
P50
description
investigador
@es
researcher
@en
name
Mattias F Lindberg
@en
type
label
Mattias F Lindberg
@en
prefLabel
Mattias F Lindberg
@en
P31
P496
0000-0002-9734-8163